The effects of atorvastatin consumption in patients with type 2 diabetes

The effects of atorvastatin consumption on blood levels of sortilin, blood sugar and lipid indices in patients with type 2 diabetes

Status

Recruiting

Phases

Phase 3

Study type

Interventional

Source

IRCT

Registry ID

IRCT20231122060137N1

Enrollment

Registered

2023-12-12

Start date

2023-10-31

Completion date

Unknown

Last updated

2024-01-22

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Type 2 diabetes. Type 2 diabetes mellitus

Interventions

Intervention 1: Intervention group 1: Patients with type 2 diabetes mellitus before treatment with atorvastatin 40 mg, these diabetic patients have not received atorvastatin so far, samples will be ta

Eligibility

Sex/Gender

All

Age

19 Years to 69 Years

Inclusion criteria

Inclusion criteria: Type 2 diabetic patients have not used statin family drugs before treatment. Healthy people should visit the laboratory for a routine checkup Taking atorvastatin 40 mg/day for patients with type 2 diabetes who need treatment with this drug. Diabetic patients have diabetes for at least 2 years. Not received insulin in patients with type 2 diabetes and healthy people. Use of hypoglycemic drugs in patients with type 2 diabetes

Exclusion criteria

Exclusion criteria: Women who are pregnant or breastfeeding People who have an active infection or hepatitis B, hepatitis C, HIV, or tuberculosis History of any cancer Heart attack in the last 6 months or peripheral coronary artery disease Smoking and alcohol use Women who use contraceptives Indigestion and chronic diarrhea, failure of important organs, such as liver, lung, kidney, and brain, as well as anemia and diabetic nephropathy

Design outcomes

Primary

Measure	Time frame
The blood level of sortilin. Timepoint: The mesearment of blood level of sortilin before treatment with atorvastatin and three months after treatment with it. Method of measurement: ELISA method using ELISA reader.;The levels of blood sugar indices. Timepoint: The mesearment of blood sugar indices before treatment with atorvastatin and three months after treatment with it. Method of measurement: Photometric method using autoanalyzer.;The levels of blood lipid indices. Timepoint: The mesearment of blood lipid indices before treatment with atorvastatin and three months after treatment with it. Method of measurement: Photometric method using autoanalyzer.	—

Measure

Time frame

The blood level of sortilin. Timepoint: The mesearment of blood level of sortilin before treatment with atorvastatin and three months after treatment with it. Method of measurement: ELISA method using ELISA reader.;The levels of blood sugar indices. Timepoint: The mesearment of blood sugar indices before treatment with atorvastatin and three months after treatment with it. Method of measurement: Photometric method using autoanalyzer.;The levels of blood lipid indices. Timepoint: The mesearment of blood lipid indices before treatment with atorvastatin and three months after treatment with it. Method of measurement: Photometric method using autoanalyzer.

—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactAli Nosrati Andevari

Kerman University of Medical Sciences

nosrati.ali70@gmail.com+98 34 3132 5600

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026